Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01756001 · ClinicalTrials.gov registry record
GlowCaps Adherence Randomized Control Trial
A clinical trial of Medical Adherence, sponsored by University of Pennsylvania.
- Completed
- Registry status
- 119
- Enrollment target
- 1
- Study location
NCT01756001: Completed study of Medical Adherence, sponsored by University of Pennsylvania.
NCT01756001 is a study of Medical Adherence that has completed, run by University of Pennsylvania. The registered enrollment target is 119 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01756001, a study of Medical Adherence, has completed, sponsored by University of Pennsylvania.
- COMPLETED
- Registry status
- 119 participants
- Enrollment target
- 1
- Study location
Study Summary
This randomized control trial will explore interventions to promote medication adherence using a novel electronic device that can track daily pill use. 500 subjects will be randomized into 4 arms of the experiment. In addition to a control arm, our three arms will be: reminders, financial incentives, and reminders and financial incentives.
Primary Outcome
This is a randomized controlled study with 5 arms - 1 control and 4 interventional. The primary outcome will be the number of doses taken as directed during the course of the study.
Conditions Studied
Interventions
- DEVICE GlowCap
- BEHAVIORAL Daily email, text message, or phone call reminders
- BEHAVIORAL Paid for adherence
Study Locations (1)
Pennsylvania
- University of Pennsylvania - Philadelphia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 119 participants |
| Start Date | 2015-02 |
| Est. Completion | 2017-03-01 |
What the finished NCT01756001 record still lists
NCT01756001 is an observational study that tracks outcomes without assigning an intervention. The registered 119 participants enrollment target is mid-sized for trials with a published cap.
The record links to 1 condition, with Medical Adherence appearing as the primary indexed condition, and to 3 interventions - of which GlowCap is the first listed.
NCT01756001 reports a single indexed study location in Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT01756001 about?
NCT01756001 is a clinical study titled "GlowCaps Adherence Randomized Control Trial". This randomized control trial will explore interventions to promote medication adherence using a novel electronic device that can track daily pill use. 500 subjects will be randomized into 4 arms of the experiment. In addition to a control arm, our three arms will be: reminders, financial incentives...
What is the current status of trial NCT01756001?
This trial is currently completed. The enrollment target is 119 participants. The study started on 2015-02. Estimated completion is 2017-03-01.
What conditions does trial NCT01756001 study?
This clinical trial studies the following conditions: Medical Adherence.
What interventions are being tested in trial NCT01756001?
The interventions under investigation include: GlowCap (DEVICE), Daily email, text message, or phone call reminders (BEHAVIORAL), Paid for adherence (BEHAVIORAL).
Who is sponsoring clinical trial NCT01756001?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01756001 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04870762 · 119 participants · Phase 2
Customized 3D Printed Oral Stents During Head and Neck Radiotherapy
- NCT05559853 · 119 participants
Developing a New MRI Technique to Understand Changes in Brain Tumors After Treatment
- NCT06564389 · 119 participants · Phase 1
FIH Study to Evaluate the Tolerability of PF-07832837 in Healthy Adults and Patients
- NCT06742801 · 119 participants · NA
Onyx™ Liquid Embolic IDE Clinical Study
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia